Based on the visual information and supporting evidence, S100B binds to the V-domain of the RAGE receptor. It should be considered a prognostic marker for neurological disorders because its levels correlate with disease severity and patient outcomes, rather than being used solely as an adjunct marker, for which it lacks the necessary specificity.